Previous 10 | Next 10 |
2023-12-07 03:04:44 ET Japan ( NKY:IND ) -1.76%. The index of coincident economic indicators in Japan, which covers a range of data, such as factory output, employment, and retail sales, ticked higher to 115.9 in October 2023 from an upwardly revised 115.7 in the prior mo...
2023-12-06 02:42:19 ET Japan ( NKY:IND ) +2.04% . The Reuters Tankan sentiment index for manufacturers in Japan jumped to +12 in December 2023 from +6 in November, improving for the second straight month. China ( SHCOMP ) -0.09% . Investors now look a...
2024 Award Celebrates Outstanding Research in Cancer Immunology Winners Discovered Novel Connections Between the Immune System and Cancer Recipients Each Receive Unrestricted USD 200,000 Awards Takeda ( TSE:4502/NYSE:TAK ) and The New York Academy of Sciences today...
2023-12-05 02:59:08 ET More on Asia EWJ: Growth Story Emerges But Major Monetary Issues Remain China's industrial profits continue to shrink in November at slower pace Japanese yen gains as Bank of Japan is poised to tweak yield-curve control - report Asi...
2023-12-04 02:24:58 ET More on Asia Bank of Japan: Last Man Standing With Negative Interest Rate Policy - May End Soon Japan's factory activity contracts for the sixth straight month in November For further details see: Asian markets mixed as investors look ahead...
2023-11-29 13:38:43 ET More on Aeglea BioTherapeutics Aeglea Biotherapeutics announces name change to Spyre Therapeutics Aeglea BioTherapeutics announces 1-for-25 reverse stock split Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics Historical ear...
2023-11-29 02:49:33 ET Japan ( NKY:IND ) -0.26% . Japan’s 10-year government bond yield fell below 0.7%, sliding to its lowest levels in nearly three months. Markets also look ahead to key economic data this week, with Japanese retail sales and industrial produc...
2023-11-28 12:33:17 ET Summary Ascendis Pharma A/S reported strong sequential growth of Skytrofa and raised its full-year net sales guidance range. The NDA resubmission for TransCon PTH is expected by mid-November, with FDA feedback by mid-December and a potential PDUFA date in Ja...
2023-11-27 17:41:15 ET Summary ImmunoGen, Inc. expects to convert the Accelerated Approval of its drug Elahere to "Full Approval" in the 1st half of 2024. Potential European approval of Elahere for treatment of patients with FRa-high platinum-resistant ovarian cancer expected late...
Company to Feature 17 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology Hematology Presentations Include New Data from the Phase 3 and Continuation Trials Supporting the Recent U.S. FDA Approval of ADZYNMA (ADAMTS13, recombinant-krhn) Oncology P...
News, Short Squeeze, Breakout and More Instantly...
Takeda Pharmaceutical Company Limited American Depositary Shares Company Name:
TAK Stock Symbol:
NYSE Market:
Takeda Pharmaceutical Company Limited American Depositary Shares Website:
2024-07-04 20:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today. Takeda's Board of Directors has 11 members servi...
LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase 1 CMV Is One of the Most Common and Serious Post-transplant Infections and Can Lead to Secondary Infections and Serious Consequences, Including Loss of Trans...